METHOTREXATE REDUCED TNF BIOACTIVITY BY ANTI-INFLIXIMAB ANTIBODY PREVENTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB

被引：0
|
作者：
Denarie, D. [1 ]
Rinaudo, M. [2 ]
Thomas, T. [1 ]
Paul, S. [2 ]
Marotte, H. [1 ]
机构：
[1] Chu St Etienne France, Rheumatol Unit, St Etienne, France
[2] Chu St Etienne France, Immunol & Immunomonitoring Dept, St Etienne, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3296
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0109
引用
收藏
页码：459 / 459
页数：1
相关论文
共 50 条
  • [11] Autoantibodies in rheumatoid arthritis treated with recombinant anti-TNF (infliximab)
    Wong, V
    Barr, S
    Martin, L
    Steber, W
    Fritzler, M
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (07) : 1434 - 1434
  • [12] ESTABLISHING CUT-OFF OF INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES BY COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, Diana
    Valor, Lara
    de la Torre, Inmaculada
    Martinez, Lina
    Carlos Nieto, Juan
    del Rio, Tamara
    Naredo, Esperanza
    Gonzalez, Carlos
    Lopez-Longo, Javier
    Montoro, Maria
    Monteagudo, Indalecio
    Carreno, Luis
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A11 - A11
  • [13] Infliximab and anti-infliximab antibody levels in Crohn's disease
    Hendy, Philip
    FRONTLINE GASTROENTEROLOGY, 2014, 5 (04) : 227 - 228
  • [14] Bone tissue metabolism in rheumatoid arthritis patients treated with infliximab and methotrexate
    Zon-Giebel, A
    Kucharz, E
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 221 - 221
  • [15] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab plus methotrexate
    Doyle, M. K.
    Rahman, M. U.
    Han, C.
    Han, J.
    Giles, J. T.
    Bingham, C. O., III
    Bathon, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 168 - 168
  • [16] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab plus methotrexate
    Doyle, M.
    Rahman, M.
    Han, C.
    Han, J.
    Giles, J. T.
    Bingham, C. O.
    Bathon, J. M.
    RHEUMATOLOGY, 2008, 47 : II39 - II40
  • [17] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    van der Maas, Aatke
    van den Bemt, Bart J. F.
    Wolbink, Gertjan
    van den Hoogen, Frank H. J.
    van Riel, Piet L. C. M.
    den Broeder, Alfons A.
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [18] Infliximab (anti-TNF-alpha antibody) improved insulin resistance in rheumatoid arthritis patients
    Sayo, Y
    Dobashi, H
    Matsubara, S
    Ino, M
    Tada, S
    Taminato, T
    Ishida, T
    DIABETES, 2004, 53 : A160 - A161
  • [19] Infliximab (Anti-TNF-alpha antibody) improved insulin resistance in rheumatoid arthritis patients
    Sayo, Y
    Dobashi, H
    Matubara, S
    Tada, S
    Taminato, T
    Ishida, T
    DIABETES, 2005, 54 : A149 - A149
  • [20] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    Aatke van der Maas
    Bart JF van den Bemt
    Gertjan Wolbink
    Frank HJ van den Hoogen
    Piet LCM van Riel
    Alfons A den Broeder
    BMC Musculoskeletal Disorders, 13
12345